Profound Medical annual free cash flow
2021
2025
Profound Medical Free Cash Flow (FCF) History (PROF)
Profound Medical reported −$38.4M in free cash flow for fiscal 2025, a decrease of $16.0M from the previous fiscal year, with a free cash flow margin of −238.43%.
View full Profound Medical company overviewProfound Medical free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$38.4M | −$16.0M | — | −238.43% |
| 2021 | 2021-12-31 | −$22.4M | — | — | −325.80% |
Profound Medical quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Profound Medical free cash flow growth trends
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Profound Medical filings at SEC.gov ↗